The pediatric microbiome and the lung

Current Opinion in Pediatrics

Volumn 27, Issue 3, 2015, Pages 348-355

  Tracy, Michael ^a   Cogen, Jonathan ^b,c   Hoffman, Lucas R ^b,c,d  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

airway; gastrointestinal; lung disease; microbiome; respiratory

Indexed keywords

AIRWAY; CYSTIC FIBROSIS; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; LUNG DISEASE; MICROBIOME; PEDIATRICS; PRIORITY JOURNAL; REVIEW; CHILD; IMMUNOLOGY; LUNG; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE;

CHILD; GASTROINTESTINAL TRACT; HUMANS; LUNG; MICROBIOTA; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASES;

EID: 84947578899     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000212     Document Type: Review

References (63)

1. Institute of Medicine (U.S.). The human microbiome, diet, and health: workshop summary. Washington, DC: National Academies Press; 2013.
2. Laurenzi GA, Berman L, First M, Kass EH. A quantitative study of the deposition and clearance of bacteria in the murine lung. J Clin Invest 1964; 43:759-768.
3. Lagier J-C, Million M, Hugon P, et al. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol 2012; 2:136.
4. Moore WE, Holdeman LV. Special problems associated with the isolation and identification of intestinal bacteria in fecal flora studies. Am J Clin Nutr 1974; 27:1450-1455.
5. Staley JT, Konopka A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu Rev Microbiol 1985; 39:321-346.
6. Vartoukian SR, Palmer RM, Wade WG. Strategies for culture of 'unculturable' bacteria. FEMS Microbiol Lett 2010; 309:1-7.
7. NIH HMP Working Group. Peterson J, Garges S, Giovanni M, et al. The NIH Human Microbiome Project. Genome Res 2009; 19:2317-2323.
8. Huang YJ, Charlson ES, Collman RG, et al. The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. Am J Respir Crit Care Med 2013; 187:1382-1387.
9. Rogers GB, Shaw D, Marsh RL, et al. Respiratory microbiota: addressing clinical questions, informing clinical practice. Thorax 2015; 70:74-81.
10. Beck JM. ABCs of the lung microbiome. Ann Am Thorac Soc 2014; 11 (Suppl 1):S3-S6.
11. Tunney MM, Klem ER, Fodor AA, et al. Useof culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 2011; 66:579-584.
12. Chmiel JF, Aksamit TR, Chotirmall SH, et al. Antibiotic management of lung infections in cystic fibrosis: part I. The microbiome, MRSA, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc 2014; 11:1120-1129.
13. Cox MJ, Cookson WOCM, Moffatt MF. Sequencing the human microbiome in health and disease. Hum Mol Genet 2013; 22:R88-94.
14. Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 2013; 7:245-257.
15. Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax 2012; 67:456-463.
16. Cox MJ, Allgaier M, Taylor B, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PloS One 2010; 5:e11044.
17. Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet 2014; 384:691-702.
18. Charlson ES, Bittinger K, Haas AR, et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011; 184:957-963.
19. Blainey PC, Milla CE, Cornfield DN, Quake SR. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med 2012; 4:153ra130.
20. Willner D, Haynes MR, Furlan M, et al. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J 2012; 6:471-474.
21. Rudkjøbing VB, Thomsen TR, Alhede M, et al. The microorganisms in chronically infected end-stage and nonend-stage cystic fibrosis patients. FEMS Immunol Med Microbiol 2012; 65:236-244.
22. Charlson ES, Bittinger K, Chen J, et al. Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts. PloS One 2012; 7:e42786.
23. Goddard AF, Staudinger BJ, Dowd SE, et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci USA 2012; 109:13769-13774.
24. Brown PS, Pope CE, Marsh RL, et al. Directly sampling the lung of a young child with cystic fibrosis reveals diverse microbiota. Ann Am Thorac Soc 2014; 11:1049-1055.
25. Di Sant'Agnese PEA, Andersen DH. Celiac syndrome; chemotherapy in infections of the respiratory tract associated with cystic fibrosis of the pancreas; observations with penicillin and drugs of the sulfonamide group, with special reference to penicillin aerosol. Am J Dis Child 1946; 72:17-61.
26. Hoegger MJ, Fischer AJ, McMenimen JD, et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science 2014; 345:818-822.
27. Stoltz DA, Meyerholz DK, Pezzulo AA, et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2010; 2:29ra31.
28. Abou Alaiwa MH, Reznikov LR, Gansemer ND, et al. pH modulates the activity and synergism of the airway surface liquid antimicrobials b-defensin-3 and LL-37. Proc Natl Acad Sci USA 2014; 111:18703-18708.
29. LiPuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010; 23:299-323.
30. Ferkol T, Rosenfeld M, Milla CE. Cystic fibrosis pulmonary exacerbations. J Pediatr 2006; 148:259-264.
31. Stressmann FA, Rogers GB, Marsh P, et al. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J Cyst Fibros Off J Eur Cyst Fibros Soc 2011; 10:357-365.
32. Zemanick ET, Wagner BD, Harris JK, et al. Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures. Pediatr Pulmonol 2010; 45:569-577.
33. Regelmann WE, Elliott GR, Warwick WJ, Clawson CC. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 1990; 141:914-921.
34. Smith AL, Fiel SB, Mayer-Hamblett N, et al. Susceptibility testing of Pseu-domonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 2003; 123:1495-1502.
35. Hurley MN, Ariff AHA, Bertenshaw C, et al. Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis. J Cyst Fibros Off J Eur Cyst Fibros Soc 2012; 11:288-292.
36. Conrad D, Haynes M, Salamon P, et al. Cystic fibrosis therapy: a community ecology perspective. Am J Respir Cell Mol Biol 2013; 48:150-156.
37. Rogers GB, Carroll MP, Serisier DJ, et al. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16S ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2004; 42:5176-5183.
38. Armougom F, Bittar F, Stremler N, et al. Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. Eur J Clin Microbiol Infect Dis 2009; 28:1151-1154.
39. Carmody LA, Zhao J, Schloss PD, et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 2013; 10: 179-187.
40. Zhao J, Schloss PD, Kalikin LM, et al. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci USA 2012; 109: 5809-5814.
41. Zhao J, Murray S, Lipuma JJ. Modeling the impact of antibiotic exposure on human microbiota. Sci Rep 2014; 4:4345.
42. Fodor AA, Klem ER, Gilpin DF, et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PloS One 2012; 7:e45001.
43. Stressmann FA, Rogers GB, van der Gast CJ, et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 2012; 67:867-873.
44. Van der Gast CJ, Cuthbertson L, Rogers GB, et al. Three clinically distinct chronic pediatric airway infections share a common core microbiota. Ann Am Thorac Soc 2014; 11:1039-1048.
45. Harris JK, De Groote MA, Sagel SD, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 2007; 104:20529-20533.
46. Maughan H, Cunningham KS, Wang PW, et al. Pulmonary bacterial communities in surgically resected noncystic fibrosis bronchiectasis lungs are similar to those in cystic fibrosis. Pulm Med 2012; 2012:746358.
47. Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the 'healthy' smoker and in COPD. PLoS One 2011; 6:e16384.
48. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PloS One 2010; 5:e8578.
49. Huang YJ, Nelson CE, Brodie EL, et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127:372-381.
50. Goleva E, Jackson LP, Harris JK, et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 2013; 188:1193-1201.
51. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-227.
52. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107:11971-11975.
53. Biesbroek G, Bosch AATM, Wang X, et al. The impact of breastfeeding on nasopharyngeal microbial communities in infants. Am J Respir Crit Care Med 2014; 190:298-308.
54. Fouhy F, Guinane CM, Hussey S, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following par-enteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012; 56:5811-5820.
55. Madan JC, Koestler DC, Stanton BA, et al. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy. interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 2012; 3:; pii: e00251-12. doi: 10.1128/mBio.00251-12.
56. Bisgaard H, Bønnelykke K, Stokholm J. Immune-mediated diseases and microbial exposure in early life. Clin Exp Allergy 2014; 44:475-481.
57. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336:1268-1273.
58. Fujimura KE, Demoor T, Rauch M, et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci USA 2014; 111:805-810.
59. Martinez FD. The human microbiome. Early life determinant of health out-comes. Ann Am Thorac Soc 2014; 11 (Suppl 1):S7-S12.
60. Hoffman LR, Pope CE, Hayden HS, et al. Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis. Clin Infect Dis Off Publ Infect Dis Soc Am 2014; 58:396-399.
61. Fallahi G, Motamed F, Yousefi A, et al. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis. Turk J Pediatr 2013; 55:475-478.
62. Weiss B, Bujanover Y, Yahav Y, et al. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis. A pilot study. Pediatr Pulmonol 2010; 45:536-540.
63. Bruzzese E, Raia V, Gaudiello G, et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 2004; 20:813-819.